Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   



Processing
Collecting data for ACUR

Acura quote and profile

    
2.77
  
STOCK
(0.11)  Macroaxis: -3.82 Down   3.82%  
 2.28 Year To Date 6.8 
 2.67 Trading Day  2.87 

Diversification Suggestion

Use Acura to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals

1 Month Beta ..........

2.1
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Acura will likely underperform.
Acura Pharmaceuticals Inc. Large Beta
ACUR United States AMEX
Acura Pharmaceuticals Inc.
 
Trade Acura
Current Valuation98.87 M
Shares Outstanding45.86 M
Number of Shares Shorted1.27 M
Revenue20.23 M
 United States SP 500   0.14 % Macroaxis: 0.14 Moved Up  
 
 United States NASDAQ   0.38 % Macroaxis: 0.38 Moved Down  
 
 thisRed ACUR ACUR agains markets  3.82 % Macroaxis: change 3.82 Moved Down  
 

Acura Leadership

Robert Jones Chief Executive officer and President and Director, MBA
Richard Markham Non-Executive Chairman of the Board
James Emigh Vice President - Marketing and Administration
J Rivet Vice President - Marketing

Acura Price and Market Media

The median price of Acura for the period between Wed, Apr 25, 2012 and Fri, May 25, 2012 is 2.88 with a coefficient of variation of 7.45. The daily time series for the period is distributed with a sample standard deviation of 0.22, arithmetic mean of 2.9, and mean deviation of 0.18. The Stock did not receive any noticable media coverage during the period.
Acura         Market
Price Growth (%)
 
Timeline

Acura Summary

Acura Pharmaceuticals Inc. [ACUR] is traded on American Stock Exchange in USA. It is located in Palatine, IL and employs 15 people. The company currently falls under 'Small-Cap' category with current market capitalization of 127.03 M. Acura Pharmaceuticals Inc. conducts business under Healthcare sector and is part of Drug Delivery industry. This company has 45.86 M outstanding shares of which 1.27 M shares are presently shorted by private and institutional investors with about 21.0 trading days to cover.

Acura Liquidity

The company has Current Ratio of 35.09 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Discuss Acura quote and profile

       
       
    
    
Acura
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Acura Pharmaceuticals Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    

Promote Acura

    
Follow Acura with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Acura to your reader
 
Get social with Acura
 Get social with Acura 
Share Toggle social options for Acura
    

Add Acura to Your Portfolio

    
Sign in to add this equity to your portfolios   
  
 
    

Acura Research Report

    
    

Acura Executives

Peter Clemens CFO, Principal Accounting Officer, Sr. VP of Investor Relations and Secretary

Acura Directors

Immanuel Thangaraj Independent Director
George Ross Independent Director
William Skelly Independent Director
Bruce Wesson Independent Director
David Azad Director

Acura Management

Bradley Rivet VP of Marketing
Albert Brzeczko VP of Technical Affairs, Ph.D
James RPH VP of Corporate Devel.
Robert Seiser VP, Treasurer and Corporate Controller



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting